We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+11.52%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$207M
AUM Growth
+$15.9M
Cap. Flow
-$3.42M
Cap. Flow %
-1.65%
Top 10 Hldgs %
23.65%
Holding
199
New
25
Increased
36
Reduced
82
Closed
22

Top Sells

Rank Stock Value
1
KSU
Kansas City Southern
KSU
+$1.96M
2
VZ icon
Verizon
VZ
+$1.45M
3
BA icon
Boeing
BA
+$1.11M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
LRCX icon
Lam Research
LRCX
+$959K

Sector Composition

Rank Sector Weight
1 Industrials 19.32%
2 Healthcare 16.68%
3 Technology 16.17%
4 Consumer Staples 12.74%
5 Financials 11.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EL icon
76
Estee Lauder
EL
$34.8B
$819K 0.4%
2,213
-150
-6% -$50.9K
PB icon
77
Prosperity Bancshares
PB
$8.53B
$810K 0.39%
11,200
+125
+1% +$9.25K
FISV
78
Fiserv Inc
FISV
$26.6B
$798K 0.39%
7,691
-75
-1% -$7.75K
LRCX icon
79
Lam Research
LRCX
$339B
$787K 0.38%
10,950
-15,300
-58% -$959K
AXTA icon
80
Axalta
AXTA
$7.12B
$779K 0.38%
+23,525
New +$746K
TT icon
81
Trane Technologies
TT
$93B
$764K 0.37%
12,350
+100
+0.8% +$18.8K
CL icon
82
Colgate-Palmolive
CL
$69.4B
$763K 0.37%
8,938
BC icon
83
Brunswick
BC
$4.46B
$749K 0.36%
+7,435
New +$728K
NUE icon
84
Nucor
NUE
$58.7B
$735K 0.36%
6,435
+1,185
+23% +$130K
GS icon
85
Goldman Sachs
GS
$284B
$727K 0.35%
1,900
+575
+43% +$228K
FDX icon
86
FedEx
FDX
$73B
$714K 0.35%
2,761
-2,889
-51% -$693K
AMAT icon
87
Applied Materials
AMAT
$334B
$713K 0.34%
4,530
-500
-10% -$72.4K
ELAN icon
88
Elanco Animal Health
ELAN
$11.5B
$697K 0.34%
24,550
+9,550
+64% +$297K
TOL icon
89
Toll Brothers
TOL
$12.4B
$691K 0.33%
9,550
+5,625
+143% +$362K
WH icon
90
Wyndham Hotels & Resorts
WH
$5.01B
$686K 0.33%
+7,650
New +$639K
QSR icon
91
Restaurant Brands International
QSR
$26.3B
$672K 0.32%
11,074
-2,420
-18% -$143K
CI icon
92
Cigna
CI
$76.3B
$671K 0.32%
2,920
-2,630
-47% -$559K
MPC icon
93
Marathon Petroleum
MPC
$115B
$669K 0.32%
+10,450
New +$672K
KNX icon
94
Knight Transportation
KNX
$11.1B
$664K 0.32%
10,895
SUM
95
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$648K 0.31%
+16,425
New +$601K
RBLX icon
96
Roblox
RBLX
$35.9B
$626K 0.3%
6,065
+3,215
+113% +$312K
WSM icon
97
Williams-Sonoma
WSM
$26.1B
$622K 0.3%
+7,350
New +$685K
AMGN icon
98
Amgen
AMGN
$203B
$621K 0.3%
2,760
-335
-11% -$70.7K
ALB icon
99
Albemarle
ALB
$13.4B
$619K 0.3%
2,650
-25
-0.9% -$6.19K
REGN icon
100
Regeneron Pharmaceuticals
REGN
$79.7B
$616K 0.3%
975
+360
+59% +$221K

Similar funds

New England Research & Management's Q4 2021 Portfolio in Review

As of Q4 2021, New England Research & Management held 199 positions worth $207M, up 8.3% from $191M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management's Q4 2021 filing shows 25 new, 36 increased, 82 reduced and 22 closed positions. Its largest new stake was HILTON HOTELS CORP: 11,725 shares worth $1.83M. The largest sale was Kansas City Southern, an estimated $1.96M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • New England Research & Management's largest Q4 2021 buy was HILTON HOTELS CORP: 11,725 shares worth $1.83M.
  • New England Research & Management added most to Canadian Pacific Kansas City in Q4 2021, an estimated $1.5M increase.
  • New England Research & Management's biggest Q4 2021 reduction was Verizon, cutting an estimated $1.45M.
  • New England Research & Management fully exited Kansas City Southern in Q4 2021, selling an estimated $1.96M.
  • New England Research & Management's ten largest holdings make up 24% of its $207M portfolio in Q4 2021.
  • New England Research & Management opened 25 new positions and closed 22 in Q4 2021.
  • New England Research & Management's portfolio value rose 8.3% quarter-over-quarter to $207M.

Based on New England Research & Management's 13F filing for Q4 2021, filed 5 Jan 2022.